BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 16386530)

  • 1. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cardiovascular disease during the first 2 years after renal transplantation.
    Laurés AS; Gómez E; Baltar J; Alvarez-Grande J
    Transplant Proc; 2005 Nov; 37(9):3778-81. PubMed ID: 16386536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G; Daniel V; Naujokat C; Döhler B
    Transplantation; 2009 Oct; 88(8):962-7. PubMed ID: 19855238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients.
    Ozdemir FN; Akgul A; Altunoglu A; Bilgic A; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):990-2. PubMed ID: 17524871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M; Ahmadi H; Baradaran N; Montaser-Kouhsari L; Salem S; Mehrsai A; Kalantar E; Jahani Y; Pourmand G
    Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients.
    Courivaud C; Bamoulid J; Chalopin JM; Gaiffe E; Tiberghien P; Saas P; Ducloux D
    J Infect Dis; 2013 May; 207(10):1569-75. PubMed ID: 23417659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
    Humar A; Washburn K; Freeman R; Paya CV; Mouas H; Alecock E; Razonable RR;
    Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
    Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
    Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients.
    Humar A; Malkan G; Moussa G; Greig P; Levy G; Mazzulli T
    J Infect Dis; 2000 Apr; 181(4):1450-3. PubMed ID: 10762575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses].
    Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP
    Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human beta-herpesvirus interactions in solid organ transplant recipients.
    Mendez JC; Dockrell DH; Espy MJ; Smith TF; Wilson JA; Harmsen WS; Ilstrup D; Paya CV
    J Infect Dis; 2001 Jan; 183(2):179-184. PubMed ID: 11120923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.
    Razonable RR; Brown RA; Humar A; Covington E; Alecock E; Paya CV;
    J Infect Dis; 2005 Oct; 192(8):1331-9. PubMed ID: 16170749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A; Kahala K; Vahlberg T; Koskela P; Vainionpää R
    BJOG; 2005 Jan; 112(1):50-6. PubMed ID: 15663397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
    Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.